Cadwell Carlton M has made headlines with a recent SEC filing detailing significant transactions involving convertible preferred shares in Vivos Inc. This move could indicate a strategic shift in ownership structure and may have broader implications for the surgical and medical instruments industry.
Background
Cadwell Carlton M is an individual investor, as indicated by the SEC filings. The recent filing, dated October 8, 2026, falls under the category of Form 4, which is used to report changes in ownership. The company involved in the transactions is Vivos Inc., which operates in the surgical and medical instruments and apparatus sector.
What the Filing Says
The filing reveals that on October 7, 2026, Carlton M Cadwell engaged in two significant transactions involving convertible preferred shares of Vivos Inc. The first transaction involved the exchange of 385,302 shares of Series C Convertible Preferred for an equal number of Series D Convertible Preferred shares. The second transaction involved a purchase of 250,000 shares of Series D Preferred for a total price of $250,000. Notably, these transactions were exempt from Section 16(b) of the Securities Exchange Act of 1934, as stated in the filing.
Impact
These transactions may affect Vivos Inc. directly, as they alter the ownership landscape. Cadwell, who is both a director and a ten-percent owner of Vivos, now holds 635,302 shares of Series D Convertible Preferred following these transactions. This change could influence decision-making within the company, particularly as it navigates its position in the competitive surgical and medical instruments industry.
What's Next
The filing does not specify what happens next regarding these transactions or any further actions by Cadwell Carlton M or Vivos Inc.
Source: SEC Filing Accession Number 0001486807-26-000002